Stockreport

bioAffinity’s CyPath® Lung Cancer Test Supported by Newly Published Flow Cytometry Guidelines

bioAffinity Technologies, Inc.  (BIAF) 
PDF bioAffinity VP served on expert panel that published new guidance SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies’ (Nasdaq: BIAF; BIAFW) Vice President of Diag [Read more]